Man Group PLC Cardiff Oncology, Inc. Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Man Group PLC holds 53,357 shares of CRDF stock, worth $168,608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,357
Previous 112,756
52.68%
Holding current value
$168,608
Previous $602,000
80.4%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRDF
# of Institutions
100Shares Held
12.8MCall Options Held
823KPut Options Held
78K-
Black Rock Inc. New York, NY2.63MShares$8.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$6.86 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA928KShares$2.93 Million0.0% of portfolio
-
State Street Corp Boston, MA833KShares$2.63 Million0.0% of portfolio
-
Mai Capital Management663KShares$2.1 Million0.02% of portfolio
About Cardiff Oncology, Inc.
- Ticker CRDF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,334,900
- Market Cap $137M
- Description
- Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...